NO20084826L - Ny administrasjonsform av racecadotril - Google Patents

Ny administrasjonsform av racecadotril

Info

Publication number
NO20084826L
NO20084826L NO20084826A NO20084826A NO20084826L NO 20084826 L NO20084826 L NO 20084826L NO 20084826 A NO20084826 A NO 20084826A NO 20084826 A NO20084826 A NO 20084826A NO 20084826 L NO20084826 L NO 20084826L
Authority
NO
Norway
Prior art keywords
racecadotril
administration form
new administration
new
raccoadotril
Prior art date
Application number
NO20084826A
Other languages
English (en)
Other versions
NO342977B1 (no
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37552919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084826(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of NO20084826L publication Critical patent/NO20084826L/no
Publication of NO342977B1 publication Critical patent/NO342977B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår en ny racecadotrilformulering i form av tabletter, fremstillingsprosessen derav og anvendelsen derav for å behandle diaré.
NO20084826A 2006-05-15 2008-11-18 Racecadotriltablett, fremgangsmåte for fremstilling av slike og slike tabletter for behandling av diaré NO342977B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604302A FR2900823B1 (fr) 2006-05-15 2006-05-15 Nouvelle forme d'administration du racecadotril.
PCT/FR2007/000814 WO2007132091A1 (fr) 2006-05-15 2007-05-14 Nouvelle forme d'administration du racecadotril

Publications (2)

Publication Number Publication Date
NO20084826L true NO20084826L (no) 2008-12-12
NO342977B1 NO342977B1 (no) 2018-09-17

Family

ID=37552919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084826A NO342977B1 (no) 2006-05-15 2008-11-18 Racecadotriltablett, fremgangsmåte for fremstilling av slike og slike tabletter for behandling av diaré

Country Status (28)

Country Link
US (1) US8318203B2 (no)
EP (1) EP2018158B1 (no)
KR (1) KR101432116B1 (no)
CN (2) CN101442990A (no)
AP (1) AP2627A (no)
AU (1) AU2007251471B2 (no)
BR (1) BRPI0710405B8 (no)
CA (1) CA2652023C (no)
CY (1) CY1114190T1 (no)
DK (1) DK2018158T3 (no)
EA (1) EA014707B1 (no)
EC (1) ECSP088889A (no)
ES (1) ES2421929T3 (no)
FR (1) FR2900823B1 (no)
HR (1) HRP20130624T1 (no)
IL (1) IL195270A (no)
MA (1) MA30466B1 (no)
MX (1) MX2008014554A (no)
NO (1) NO342977B1 (no)
NZ (1) NZ573424A (no)
PL (1) PL2018158T3 (no)
PT (1) PT2018158E (no)
RS (1) RS52912B (no)
SI (1) SI2018158T1 (no)
TN (1) TNSN08428A1 (no)
UA (1) UA98299C2 (no)
WO (1) WO2007132091A1 (no)
ZA (1) ZA200809721B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
CN102133186B (zh) * 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
RU2632441C2 (ru) * 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
EP3086777A1 (en) * 2013-12-23 2016-11-02 Johnson & Johnson Consumer Inc. Racecadotril compositions
MA39009A (fr) 2014-03-10 2015-09-16 Galenicum Health Sl Compositions pharmaceutiques comprenant un agent actif
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
CN107438431B (zh) * 2015-02-09 2020-12-15 瑞沃制药股份公司 消旋卡多曲的药物制剂
CN106822907B (zh) * 2016-12-29 2021-02-09 山东达因海洋生物制药股份有限公司 一种含消旋卡多曲的双相释放制剂及其制备方法
WO2018163195A1 (en) * 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
AU2001289606A1 (en) 2000-06-23 2002-01-02 Societe Civile Bioprojet Dry powder formulation comprising racecadotril
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
EP1563848A1 (en) 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
HRP20100682T4 (hr) * 2004-08-13 2014-08-01 Boehringer Ingelheim International Gmbh Formulacija tablete produljenog oslobađanja koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu sol, postupak njezine priprave i uporaba
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome

Also Published As

Publication number Publication date
EA014707B1 (ru) 2011-02-28
BRPI0710405A2 (pt) 2011-08-09
EA200802324A1 (ru) 2009-04-28
FR2900823A1 (fr) 2007-11-16
CA2652023C (fr) 2016-06-28
NZ573424A (en) 2012-03-30
EP2018158A1 (fr) 2009-01-28
SI2018158T1 (sl) 2013-09-30
WO2007132091A1 (fr) 2007-11-22
AU2007251471A1 (en) 2007-11-22
FR2900823B1 (fr) 2009-02-13
KR101432116B1 (ko) 2014-08-21
NO342977B1 (no) 2018-09-17
KR20090017593A (ko) 2009-02-18
ECSP088889A (es) 2009-01-30
RS52912B (sr) 2014-02-28
BRPI0710405B8 (pt) 2021-05-25
AU2007251471B2 (en) 2012-03-15
US20090186084A1 (en) 2009-07-23
PL2018158T3 (pl) 2013-09-30
TNSN08428A1 (fr) 2010-04-14
IL195270A0 (en) 2009-08-03
ZA200809721B (en) 2009-06-24
IL195270A (en) 2016-08-31
CN103961328A (zh) 2014-08-06
BRPI0710405B1 (pt) 2019-01-08
PT2018158E (pt) 2013-07-24
ES2421929T3 (es) 2013-09-06
EP2018158B1 (fr) 2013-04-24
MX2008014554A (es) 2008-11-27
AP2008004686A0 (en) 2008-12-31
US8318203B2 (en) 2012-11-27
CY1114190T1 (el) 2016-08-31
HRP20130624T1 (en) 2013-08-31
MA30466B1 (fr) 2009-06-01
CN101442990A (zh) 2009-05-27
CA2652023A1 (fr) 2007-11-22
DK2018158T3 (da) 2013-07-22
AP2627A (en) 2013-03-26
UA98299C2 (ru) 2012-05-10

Similar Documents

Publication Publication Date Title
NO20084826L (no) Ny administrasjonsform av racecadotril
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
UA94129C2 (ru) Соединения для ингибирования митоза
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
MY164646A (en) Nicotine lozenge compositions
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
BR112012021337A8 (pt) formulações de apixaban.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NO20084256L (no) DPP IV inhibitorformuleringer
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
NO20084850L (no) MGLUR5 modulatorer I
GB0625648D0 (en) Compounds
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
NO20092584L (no) Farmasoytiske sammensetninger og deres fremgangsmater for anvendelse
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
NO20084852L (no) MGLUR5 modulatorer V
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
MX2009001494A (es) 2-aminobenzoxazol carboxamidas como moduladores 5ht3.
WO2007130822A3 (en) Mglur5 modulators iii
MX2009013501A (es) Compuestos piperidinicos y sus usos.
WO2007130821A3 (en) Mglur5 modulators ii
WO2009032843A3 (en) Deuterated ethambutols and their use
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.